A prototype AI chatbot tool has been developed to help pull together vital human, animal and environmental health information to support the global response to antimicrobial resistance (AMR).
North Chicago-based Abbott announced last month it reached a settlement agreement with Dexcom over all outstanding patent disputes relating to their glucose monitoring products, which estimate blood ...